{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:41:40Z","timestamp":1740163300063,"version":"3.37.3"},"reference-count":15,"publisher":"BMJ","issue":"e3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2023,7,5]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Little is known about the adverse effects associated with antidepressant use in palliative care inpatients imminently approaching death. This study investigates the relationship between antidepressant use and hyperactive delirium in this population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a retrospective medical record review of patients who died in a metropolitan palliative care unit in Victoria, Australia, during 2019. Generalised estimating equations were used to estimate the association between antidepressant use and presence of hyperactive delirium in the final 2\u2009weeks of life.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 501 adult patients who died in the 12-month period, 113 (22.55%) were on at least one antidepressant at the time of admission. Any antidepressant use in the last 14 days of life was significantly associated with the diagnosis of hyperactive delirium (OR 1.48; 95% CI 1.30, 1.68). Patients prescribed antidepressants also experienced longer durations of delirium (3.89 days; SD 4.23) compared with those not taking any antidepressant (2.99 days; SD 3.70) in the final 2\u2009weeks of life.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Antidepressant use or discontinuation is significantly associated with hyperactive delirium within 14 days of death. Although the causes of delirium are multifactorial and complex, antidepressant use is a potentially modifiable risk factor.<\/jats:p><\/jats:sec>","DOI":"10.1136\/spcare-2023-004417","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T17:20:53Z","timestamp":1689960053000},"page":"e916-e919","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Antidepressant use and hyperactive delirium at the end of life: retrospective study"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1226-7107","authenticated-orcid":false,"given":"Naomi","family":"Gleadle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angus","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire E","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Walpole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"2024121022580585000_13.e3.e916.1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/imj.15320","article-title":"Examining antidepressant use in palliative care patients by risk of antidepressant discontinuation syndrome","volume":"51","author":"Glanger","year":"2021","journal-title":"Intern Med J"},{"key":"2024121022580585000_13.e3.e916.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2014.147"},{"key":"2024121022580585000_13.e3.e916.3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12877-018-0733-3","article-title":"Clinical characteristics associated with the onset of delirium among long-term nursing home residents","volume":"18","author":"Cheung","year":"2018","journal-title":"BMC Geriatr"},{"key":"2024121022580585000_13.e3.e916.4","doi-asserted-by":"publisher","DOI":"10.2165\/11592240-000000000-00000"},{"key":"2024121022580585000_13.e3.e916.5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejcsup.2013.07.008","article-title":"Drug-associated delirium in cancer patients","volume":"11","author":"Caraceni","year":"2013","journal-title":"EJC Suppl"},{"key":"2024121022580585000_13.e3.e916.6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004850-200015040-00009","article-title":"Occurrence of Mirtazapine-induced delirium in organic brain disorder","volume":"15","author":"Bailer","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"2024121022580585000_13.e3.e916.7","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.89a.21020"},{"key":"2024121022580585000_13.e3.e916.8","doi-asserted-by":"crossref","first-page":"20451253211067656","DOI":"10.1177\/20451253211067656","article-title":"Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review","volume":"12","author":"S\u00f8rensen","year":"2022","journal-title":"Ther Adv Psychopharmacol"},{"key":"2024121022580585000_13.e3.e916.9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4088\/JCP.v59n0509b","article-title":"FINISH: remembering the discontinuation syndrome","volume":"59","author":"Berber","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"2024121022580585000_13.e3.e916.10","first-page":"27","article-title":"Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research","volume":"67 Suppl 4","author":"Schatzberg","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"2024121022580585000_13.e3.e916.11","first-page":"174","article-title":"Antidepressant discontinuation syndrome: A common but Underappreciated clinical problem","volume":"120","author":"Rizkalla","year":"2020","journal-title":"J Am Osteopath Assoc"},{"key":"2024121022580585000_13.e3.e916.12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/jan.14966","article-title":"Symptom Trajectories for palliative care Inpatients with and without Hyperactive delirium in the last week of life","volume":"78","author":"Dai","year":"2022","journal-title":"J Adv Nurs"},{"key":"2024121022580585000_13.e3.e916.13","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0865"},{"key":"2024121022580585000_13.e3.e916.14","unstructured":"Palliative Care Outcomes Collaboration (PCOC) . In: Phase Definitions [Internet]. 2014 [Palliative Care Outcomes Collaboration. Phase Definitions [Internet]. Wollongong, Australia: Palliative Care Outcomes Collaboration, 2021. Available: https:\/\/documents.uow.edu.au\/content\/groups\/public\/@web\/@chsd\/@pcoc\/documents\/doc\/uow222232.pdf"},{"key":"2024121022580585000_13.e3.e916.15","article-title":"Medically assisted hydration for adult palliative care patients","volume":"2014","author":"Good","year":"2014","journal-title":"Cochrane Database Syst Rev"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2023-004417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T07:14:33Z","timestamp":1733901273000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2023-004417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":15,"journal-issue":{"issue":"e3","published-online":{"date-parts":[[2024,1,8]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/spcare-2023-004417"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2023-004417","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"type":"print","value":"2045-435X"},{"type":"electronic","value":"2045-4368"}],"subject":[],"published":{"date-parts":[[2023,7,21]]}}}